Molecular epidemiology of malaria in Cameroon.: IX.: Characteristics of recrudescent and persistent Plasmodium falciparum infections after chloroquine or amodiaquine treatment in children

被引:22
作者
Basco, LK
Ndounga, M
Keundjian, A
Ringwald, P
机构
[1] Cluster of Communicable Diseases, Anti-infective Drug Resistance, World Health Organization
关键词
D O I
10.4269/ajtmh.2002.66.117
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In the absence of a firmly established gene responsible for chloroquine and amodiaquine resistance in Plasmodum falciparum, surveillance of resistance to these first-line drugs in Cameroon needs to be performed by in vivo or in vitro tret tests for drug resistance. These 2 methodological approaches to define drug resistance were shown to be complementary and concordant in a majority of cases at our study sites, but discordant results may be observed in a few cases. probably as a result of acquired immunity and low plasma drug levels. To further examine the nature of recrudescent and persistent parasitemia after treatment with chloroquine or amodiaquine. the clinical response of children aged < 5 years, presumably with insufficient immune response, was assessed, and the in vitro response of the corresponding isolates was determined if treatment or parasitological failure occurred. Genotyping of pretreatment and posttreatment isolates was performed by polymerase chain reaction to distinguish between recrudescence and reinfection. Plasma drug levels were measured at the time of therapeutic failure by high-performance liquid chromatography. All cases of therapeutic or parasitological failure observed on or before Day 14 were due to the persistence or recrudescence of the original parasite populations present before treatment. with or without selection and appearance of new populations, Most parasites were characterized by elevated 50% inhibitory concentrations for chloroquine and amodiaquine at the time of clinical or parasitological failure. In some children, recrudescence was explained by the absence of drug in the plasma. The simultaneous analysis of clinical and in vitro responses, plasma drug level measurement, and genotyping may yield results that may explain the reasons for therapeutic failure, help establish the threshold level for in vitro resistance, and provide a set of more accurate tools to describe the epidemiology of drug-resistant P. falciparum while awaiting for the identification of the chloroquine and amodiaquine resistance gene or genes.
引用
收藏
页码:117 / 123
页数:7
相关论文
共 25 条
[1]  
[Anonymous], 1996, WHOMAL961077
[2]   Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria [J].
Basco, LK ;
Ringwald, P .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2000, 63 (5-6) :215-221
[3]   Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadosine-pyrimethamine in patients with acute uncomplicated falciparum malaria [J].
Basco, LK ;
Tahar, R ;
Keundjian, A ;
Ringwald, P .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (02) :624-628
[4]   PLASMODIUM-FALCIPARUM - GENE STRUCTURE AND HYDROPATHY PROFILE OF THE MAJOR MEROZOITE SURFACE-ANTIGEN (GP195) OF THE UGANDA-PALO-ALTO ISOLATE [J].
CHANG, SP ;
KRAMER, KJ ;
YAMAGA, KM ;
KATO, A ;
CASE, SE ;
SIDDIQUI, WA .
EXPERIMENTAL PARASITOLOGY, 1988, 67 (01) :1-11
[5]   STRUCTURE OF THE GENE ENCODING THE IMMUNODOMINANT SURFACE-ANTIGEN ON THE SPOROZOITE OF THE HUMAN MALARIA PARASITE PLASMODIUM-FALCIPARUM [J].
DAME, JB ;
WILLIAMS, JL ;
MCCUTCHAN, TF ;
WEBER, JL ;
WIRTZ, RA ;
HOCKMEYER, WT ;
MALOY, WL ;
HAYNES, JD ;
SCHNEIDER, I ;
ROBERTS, D ;
SANDERS, GS ;
REDDY, EP ;
DIGGS, CL ;
MILLER, LH .
SCIENCE, 1984, 225 (4662) :593-599
[6]   QUANTITATIVE ASSESSMENT OF ANTI-MALARIAL ACTIVITY INVITRO BY A SEMIAUTOMATED MICRODILUTION TECHNIQUE [J].
DESJARDINS, RE ;
CANFIELD, CJ ;
HAYNES, JD ;
CHULAY, JD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (06) :710-718
[7]   THE SINGLE DOSE KINETICS OF CHLOROQUINE AND ITS MAJOR METABOLITE DESETHYLCHLOROQUINE IN HEALTHY-SUBJECTS [J].
FRISKHOLMBERG, M ;
BERGQVIST, Y ;
TERMOND, E ;
DOMEIJNYBERG, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (04) :521-530
[8]  
Le Bras J, 1990, Med Trop (Mars), V50, P11
[9]   POLYMERASE CHAIN-REACTION AMPLIFICATION FROM PLASMODIUM-FALCIPARUM ON DRIED BLOOD SPOTS [J].
LONG, GW ;
FRIES, L ;
WATT, GH ;
HOFFMAN, SL .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (04) :344-346
[10]  
MOHAN K, 1998, MALARIA PARASITE BIO, P467